Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario
Sign Up to like & getrecommendations! Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11061520
Abstract: Glioblastoma (GBM) is the most common and aggressive central nervous system tumor, requiring multimodal management. Due to its malignant behavior and infiltrative growth pattern, GBM is one of the most difficult tumors to treat and… read more here.
Keywords: immunotherapy overview; current clinical; glioblastoma immunotherapy; clinical translational ... See more keywords